Anarghya Vardhana
Principal @ Maveron
San Francisco, United States
Anarghya Vardhana is a Series A investor at Maveron in San Francisco focused on Health Care and Consumer. Anarghya Vardhana currently works as the Partner for Maveron. She previously worked at Rothenberg Ventures as an Investor.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Anarghya Vardhana invests in
Stages Anarghya Vardhana invests in
Countries Anarghya Vardhana invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2M–$5.2M
- Series A
- $7M–$22M
- Series B
- $15M–$50M
Investment Focus
Industry
- Health Care 6 (30%)
- Consumer 4 (20%)
- Artificial Intelligence 3 (15%)
- Medical 2 (10%)
- Software 2 (10%)
Stage
- Series A 10 (50%)
- Series B 4 (20%)
- Seed 3 (15%)
- Pre-Seed 1 (5%)
- Convertible Note 1 (5%)
Country
- United States 12 (60%)
- Canada 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Goodbill identifies possible hospital billing errors and inflated charges and then automate the process of helping people pay less. | $2M / Seed / Mar 26, 2024 | ||
| Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need formental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it. | $16.8M / Series A / Jun 20, 2023 | ||
| Bend Health, Inc. is a national healthcare company that increases access and reduces the cost of expert mental health care for kids, teens, and families. Our founding team has been in both technology and healthcare for nearly twenty years, as individual contributors, and executives, in both private practices and at companies including Oracle,Optum, UnitedHealth Group and Teladoc Health. We are revolutionizing the treatment of mental health conditions for kids and teens through a novel data-driven technology platform and evidence-based collaborative care model that enables the first scalable and integrated care solution in mental health. Through coaching, therapy and reduced time to evaluation and treatment by licensed pediatric psychiatry experts, our approach achieves better outcomes and results in happier, healthier, kids/teens, while ensuring stigma, cost, and logistics are no longer barriers to care. | $27M / Series A / Mar 23, 2023 | ||
| Alife develops artificial intelligence tools to assist physicians in increasing a patient's chances of pregnancy success. The company has a mission of helping people have healthy children and connects fertility specialists to patients to assists with IVF.Alife Health was founded in 2020 by Paxton Maeder-York and is headquartered in SanFrancisco, California, United States. | $22M / Series A / Mar 22, 2022 | ||
| Goodbill identifies possible hospital billing errors and inflated charges and then automate the process of helping people pay less. | $3.4M / Seed / Dec 01, 2021 | ||
| AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes develops a platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that enables patients to participate in treatment research online andbenefit from their own medical data. | $50M / Series B / Aug 24, 2021 | ||
| Co–Star is powered by AI that merges NASA data with the insight of human astrologers.Co–Star facilitates new ways to relate to others. It’s a filter to express what can be hard to say of emotions and reactions, strengths and weaknesses, pasts and futures. It’s a tool to connect meaningfully with friends and lovers or to tread lightly with strangersand enemies. | $15M / Series A / Apr 14, 2021 | ||
| AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes develops a platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that enables patients to participate in treatment research online andbenefit from their own medical data. | $14M / Series A / Apr 16, 2020 | ||
| Two Chairs delivers the nation's best therapy at scale. Founded in 2017, the company's mission is to build a world where we all have access to exceptional mental health care. Their unique approach begins with an in-depth, research-backed process where a licensed Two Chairs clinician matches patients with their ideal therapist. Two Chairsthen uses their industry-leading system for measurement-based care to help patients get better, faster. Two Chairs is the employer of choice for over 500 licensed therapists across 90 areas of expertise and has more than 20 million covered lives. The company has earned a number of awards, including 2024 Great Place To Work and San Francisco Business Times Best Places To Work. | $21M / Series B / Dec 13, 2019 | ||
| Tempest is a digital recovery program that helps people to quit drinking and build a life they love. It specializes in the fields of health diagnostics, healthcare, and personal health. | $10M / Series A / Oct 10, 2019 | ||
| See all 20 investments → | |||
Co-Investors
About Maveron
Maveron is a consumer-only venture capital firm. Founded in 1998 by Dan Levitan and Howard Schultz, the firm has offices in San Francisco and Seattle. Maveron investments include Zulily, Allbirds, Common, August Home, eBay, Capella Education, General Assembly, and Trupanion. Maveron's name was coined from the words "maverick" and "vision." Maveron funds seed and Series A companies that empower consumers to live on their terms. Based in SF and Seattle and invest coast-to-coast. Maveron has adopted the Diversity Term Sheet Rider.
Maveron Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anarghya Vardhana
Principal
|
|||
Dan Levitan
Co-Founder and Partner
|
|||
David Wu
Partner
|
|||
Grace Chou
Partner
|
|||
Howard Schultz
Co-founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Anarghya Vardhana invest in?
Anarghya Vardhana invests primarily in Health Care, Consumer and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Anarghya Vardhana invest in?
Anarghya Vardhana typically joins rounds of $2M–$5.2M at Seed, $7M–$22M at Series A and $15M–$50M at Series B. These are whole funding-round sizes, not Anarghya Vardhana's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Anarghya Vardhana took part in.
How do I contact Anarghya Vardhana?
Public channels for Anarghya Vardhana include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anarghya Vardhana last invest?
The most recent investment recorded for Anarghya Vardhana closed in Mar 2024. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
